Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedemas”

190 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 190 results

Large-scale testing (Phase 3)Study completedNCT00456508
What this trial is testing

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 147
Post-approval studies (Phase 4)Study completedNCT06806657
What this trial is testing

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

Who this might be right for
Hereditary Angioedema
CSL Behring 18
Large-scale testing (Phase 3)Enrolling By InvitationNCT07204938
What this trial is testing

A Long-Term Study of Navenibart in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Astria Therapeutics, Inc. 145
Early research (Phase 1)Study completedNCT01760343
What this trial is testing

Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 16
Not applicableStudy completedNCT05489640
What this trial is testing

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 85
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Not applicableAvailableNCT07216378
What this trial is testing

Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Not applicableLooking for participantsNCT07293364
What this trial is testing

Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 514
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33
Not applicableLooking for participantsNCT07021495
What this trial is testing

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center 840
Testing effectiveness (Phase 2)Study completedNCT01359969
What this trial is testing

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 57
Large-scale testing (Phase 3)Study completedNCT01386658
What this trial is testing

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 32
Large-scale testing (Phase 3)Study completedNCT00262288
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Not applicableEnded earlyNCT02854397
What this trial is testing

Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population

Who this might be right for
Hereditary AngioedemaHealthy Volunteers
University Hospital, Grenoble 31
Not applicableNot Yet RecruitingNCT05833620
What this trial is testing

Identification and Characterization of Genetic Variants in Hereditary Angioedema

Who this might be right for
Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
Hospital Universitari Vall d'Hebron Research Institute 200
Testing effectiveness (Phase 2)Ended earlyNCT05047185
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34
Early research (Phase 1)Study completedNCT02663687
What this trial is testing

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

Who this might be right for
Hereditary Angioedema (HAE)
Shire 48
Large-scale testing (Phase 3)Study completedNCT02586805
What this trial is testing

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 125
Not applicableStudy completedNCT01034969
What this trial is testing

Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 1,761
Next Page